Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

NEW YORK & PITTSBURGH–(BUSINESS WIRE)–Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition…

Bitwise Announces Results of December 2022 Month-End Crypto Index Reconstitution

Intel (INTC), CBOE Global Markets (CBOE), Nu Holdings (NU), and Applied Blockchain (APLD) enter the Bitwise…

Continental and Ambarella Partner On Assisted and Automated Driving Systems With Full Software Stack

Strategic partnership: Joint development of perception solutions and full-stack systems for advanced driver assistance and highly…

Ganymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 M

The European Innovation Council (EIC) Fund, through the EIC Accelerator Program, and Cap Horn join existing…

Trade Republic Offers 2 Percent Interest on Cash for All Customers

All customers receive 2 percent p.a. interest on their cash balance Market leading annual interest rate…

Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors

PARIS–(BUSINESS WIRE)–Orano Med, a clinical stage radiopharmaceutical company, today announced that the first patient has been…

Elliptic Labs Signs Software License Contract with New Top-5 Smartphone OEM Customer

OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in…

Dell Technologies Collaborates with Unified National Networks to Accelerate the Modernization of Brunei’s Telecommunications Network

BANDAR SERI BEGAWAN, Brunei–(BUSINESS WIRE)–#Dell—Story Highlights: Dell Technologies’ compute, storage and cloud solutions help Brunei’s largest…

ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Submission based on DESTINY-Lung02 and DESTINY-Lung01 phase 2 trial results which showed Daiichi Sankyo and AstraZeneca’s…

Barclays Bank PLC Announces Results of Cash Tender Offer and Consent Solicitation for its iPath® S&P GSCI® Crude Oil Total Return Index ETNs (ticker OILNF)

NEW YORK–(BUSINESS WIRE)–Barclays Bank PLC (the “Issuer”) announced today the results of its previously announced cash…